Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Int J Mol Sci ; 24(13)2023 Jun 27.
Artigo em Inglês | MEDLINE | ID: mdl-37445897

RESUMO

The use of alternative energy sources, such as microwaves (MW) or ultrasounds (US), and their mutual cross-combination have been widely described in the literature in the development of new synthetic methodologies in organic and medicinal chemistry. In this review, our attention is focused on representative examples, reported in the literature in the year range 2013-2023 of selected N-containing bicyclic heterocycles, with the aim to highlight the advantages of microwave- and ultrasound-assisted organic synthesis.


Assuntos
Micro-Ondas , Nitrogênio , Técnicas de Química Sintética , Ultrassonografia , Química Farmacêutica
2.
Eur J Med Chem ; 269: 116292, 2024 Apr 05.
Artigo em Inglês | MEDLINE | ID: mdl-38479168

RESUMO

Selective inhibitors of DYRK1A are of interest for the treatment of cancer, Type 2 diabetes and neurological disorders. Optimization of imidazo [1,2-b]pyridazine fragment 1 through structure-activity relationship exploration and in silico drug design efforts led to the discovery of compound 17 as a potent cellular inhibitor of DYRK1A with selectivity over much of the kinome. The binding mode of compound 17 was elucidated with X-ray crystallography, facilitating the rational design of compound 29, an imidazo [1,2-b]pyridazine with improved kinase selectivity with respect to closely related CLK kinases.


Assuntos
Diabetes Mellitus Tipo 2 , Iohexol/análogos & derivados , Piridazinas , Humanos , Quinases Dyrk , Diabetes Mellitus Tipo 2/tratamento farmacológico , Inibidores de Proteínas Quinases/química , Relação Estrutura-Atividade , Piridazinas/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA